JPRN-UMIN000012004已完成2 期
Phase 2 study of ATRA and arsenic trioxide for acute promyelocytic leukemia - Phase 2 study of ATRA and arsenic trioxide for acute promyelocytic leukemia
Department of Hematology, Hiroshima University Hospital0 个研究点目标入组 45 人开始时间: 2013年10月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe co-morbidity 2. Pregnant and/or lactating woman 3. Patients who have a difficulty to enter the study.
研究者
相似试验
进行中（未招募）
2 期
Multicenter, phase II study of arsenic trioxide and all-trans retinoic acid in patients with newly diagnosed acute promyelocytic leukemia in Japan (JALSG-APL220)D015473acute promyelocytic leukemiaJPRN-jRCTs041200102Yokoyama Yasuhisa99
已完成
1 期
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AMLMyelodysplastic SyndromeNCT00195104Weill Medical College of Cornell University87
终止
2 期
Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)Systemic LupusNCT01738360Nantes University Hospital11
已完成
3 期
Effect of arsenic trioxide in induction of complete remission of acute myeloid leukemia(non m3)Acute myeloblastic leukemiaIRCT20140818018842N16Hematology, Oncology & Stem Cell Transplantation Research Center, Tehran University of Medical Sci.112
Unknown
2 期
Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular CarcinomaCarcinoma, HepatocellularNCT01861912Guangdong Provincial People's Hospital258